Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 10-2018 | 07-2018 | 04-2018 | 01-2018 | 10-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 851 | 926 | 1,093 | 2,204 | 3,304 |
| Receivables | 353 | 275 | 192 | 146 | 143 |
| Inventories | 209 | 197 | 275 | 267 | 274 |
| TOTAL | $1,484 | $1,456 | $1,612 | $2,721 | $3,896 |
| Non-Current Assets | |||||
| PPE Net | 443 | 461 | 487 | 515 | 530 |
| Intangibles | 613 | 658 | 701 | 737 | 781 |
| TOTAL | $1,056 | $1,119 | $1,188 | $1,252 | $1,311 |
| Total Assets | $2,540 | $2,575 | $2,800 | $3,973 | $5,207 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 420 | 608 | 486 | 449 | 425 |
| Accrued Expenses | 152 | 170 | 137 | 233 | 212 |
| TOTAL | $572 | $1,281 | $623 | $682 | $637 |
| Non-Current Liabilities | |||||
| TOTAL | $12 | $13 | $15 | $17 | $10 |
| Total Liabilities | $584 | $1,294 | $638 | $699 | $647 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 71,582 | 71,582 | 68,095 | 68,058 | 67,982 |
| Common Shares | 716 | 683 | 681 | 681 | 680 |
| Retained earnings | -119,490 | -116,924 | -115,540 | -113,848 | -111,821 |
| TOTAL | $1,956 | $1,281 | $2,162 | $3,274 | $4,560 |
| Total Liabilities And Equity | $2,540 | $2,575 | $2,800 | $3,973 | $5,207 |